◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
Daito Pharmaceutical Co.,Ltd. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2025May 31, 2025FY 2024May 31, 2024FY 2023May 31, 2023FY 2022May 31, 2022FY 2021May 31, 2021
+Revenue 50.6B 46.9B 45.1B 43.5B 48.7B
Revenue Growth % 8.0% 4.0% 3.8% -10.8% --
+Operating Income 2.6B 3.9B 5.2B 6.6B 5.9B
Operating Margin % 5.2% 8.3% 11.5% 15.1% 12.1%
Non Operating Income 245.0M 126.0M 86.0M 205.0M 197.9M
Non Operating Expenses 160.0M 97.0M 124.0M 29.0M 39.1M
Ordinary Income 2.7B 3.9B 5.2B 6.7B 6.1B
Income Before Taxes 3.0B 4.2B 5.1B 6.7B 5.9B
Income Taxes 1.2B 1.0B 1.5B 2.1B 1.7B
+Net Income 1.9B 3.3B 3.6B 4.7B 4.2B
Net Margin % 3.8% 7.0% 8.0% 10.7% 8.7%
Eps 62.74 210.00 250.39 335.41 311.02
Depreciation Amortization 4.3B 3.7B 3.9B 3.3B 3.2B
Line ItemFY 2025May 31, 2025FY 2024May 31, 2024FY 2023May 31, 2023FY 2022May 31, 2022FY 2021May 31, 2021
Cash And Deposits 2.2B 2.7B 3.6B 4.4B 3.4B
Current Assets 41.7B 41.5B 40.7B 37.9B 32.4B
Property Plant Equipment 31.8B 32.0B 25.8B 23.1B 21.4B
Noncurrent Assets 36.3B 36.2B 29.9B 27.0B 25.3B
Total Assets 78.0B 77.7B 70.6B 64.9B 57.7B
Current Liabilities 17.0B 18.5B 15.4B 14.1B 12.9B
Total Liabilities 25.9B 25.4B 19.6B 17.3B 15.8B
Retained Earnings 37.2B 37.1B 35.0B 32.3B 28.3B
Total Equity 52.1B 52.3B 51.0B 47.7B 41.9B
Equity Ratio 0.67 0.67 0.72 0.73 0.72
Book Value Per Share 1,734 3,405 3,527 3,310 3,035
Num Employees 1,073 1,070 1,011 915.00 846.00
Roe 0.04 0.06 0.07 0.10 0.11
Line ItemFY 2025May 31, 2025FY 2024May 31, 2024FY 2023May 31, 2023FY 2022May 31, 2022FY 2021May 31, 2021
Operating Cash Flow 5.9B 5.2B 4.2B 4.4B 5.2B
Investing Cash Flow -7.4B -5.9B -5.6B -4.4B -6.3B
Financing Cash Flow 1.0B -183.0M 616.0M 989.0M 1.4B
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...